To evaluate clinical outcomes of telephone-based service for patients on warfarin.
Methods:
Five bibliographic databases and gray literature were searched for articles that reported the effects of telephone interventions provided to patients using warfarin compared with those receiving usual clinic-based care. Mean difference (MD) and relative risk (RR) were used to calculate the effects of telephone intervention on time in therapeutic range (TTR) and visit in range (VIR), respectively. Adverse events (AEs) were pooled and reported as incidence rate ratios.
Results:
A total of 1,840 articles were examined. Eight articles involving 8,087 subjects were included in the quantitative synthesis. The pooled estimates from seven studies showed no difference on TTR between the telephone service group and the usual care group (MD 2.30; 95% confidence interval [CI] −3.56 to 8.16). In addition, VIR in the telephone service group was not different from the usual care group (RR 1.22, 95% CI 0.87–1.71). Moreover, patients in telephone service groups appeared to have a lower incidence of AEs compared with usual care groups.
Discussion:
Telephone-based service could be considered as an alternative anticoagulant management. However, owing to a lack of evidence from well-designed studies, further high-quality randomized control trials are warranted.
Get full access to this article
View all access options for this article.
References
1.
AnsellJ, HirshJ, HylekE, JacobsonA, CrowtherM, PalaretiG. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2008; 133:160S–198S.
2.
PirmohamedM. Warfarin: Almost 60 years old and still causing problems. Br J Clin Pharmacol, 2006; 62:509–511.
3.
KimmelSE. Warfarin therapy: In need of improvement after all these years. Expert Opin Pharmacother, 2008; 9:677–686.
4.
SchulmanS, BeythRJ, KearonC, LevineMN. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 2008; 133:257S–298S.
5.
HylekEM, GoAS, ChangY, JensvoldNG, HenaultLE, SelbyJV, et al.Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med, 2003; 349:1019–1026.
6.
Entezari-MalekiT, DoustiS, HamishehkarH, GholamiK. A systematic review on comparing 2 common models for management of warfarin therapy; pharmacist-led service versus usual medical care. J Clin Pharmacol, 2016; 56:24–38.
7.
ZhouS, ShengXY, XiangQ, WangZN, ZhouY, CuiYM. Comparing the effectiveness of pharmacist-managed warfarin anticoagulation with other models: A systematic review and meta-analysis. J Clin Pharm Ther, 2016; 41:602–611.
8.
SaokaewS, SapooU, NathisuwanS, ChaiyakunaprukN, PermsuwanU. Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand. Int J Clin Pharm, 2012; 34:105–112.
9.
ChristensenTD, JohnsenSP, HjortdalVE, HasenkamJM. Self-management of oral anticoagulant therapy: A systematic review and meta-analysis. Int J Cardiol, 2007; 118:54–61.
10.
HeneghanC, Alonso-CoelloP, Garcia-AlaminoJM, PereraR, MeatsE, GlasziouP. Self-monitoring of oral anticoagulation: A systematic review and meta-analysis. Lancet, 2006; 367:404–411.
11.
ManzoorBS, ChengWH, LeeJC, UppuluriEM, NutescuEA. Quality of pharmacist-managed anticoagulation therapy in long-term ambulatory settings: A systematic review. Ann Pharmacother, 2017; 51:1122–1137.
12.
Garcia-AlaminoJM, WardAM, Alonso-CoelloP, PereraR, BankheadC, FitzmauriceD, et al.Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev, 2010; CD003839.
13.
MeadeM, BorchertJ, GriffinB, KliethermesMA, KomperdaK. Impact of health disparities on staff workload in pharmacist-managed anticoagulation clinics. Am J Health Syst Pharm, 2011; 68:1430–1435.
14.
BungardT, GrantCM, AckmanML, TsuyukiRT. Anticoagulation clinics in North America: Operational insights. Can J Hosp Pharm, 2008; 61:245–246.
15.
JenningsI, KitchenD, KeelingD, FitzmauriceD, HeneghanC. Patient self-testing and self-management of oral anticoagulation with vitamin K antagonists: Guidance from the British Committee for Standards in Haematology. Br J Haematol, 2014; 167:600–607.
16.
World Health Organization. Telemedicine: Opportunities and developments in Member States: Report on the second global survey on eHealth. 2010. Available at www.who.int/goe/publications/goe_telemedicine_2010.pdf (last accessed April28, 2017).
17.
BungardTJ, RitchieB, GargS, TsuyukiRT. Sustained impact of anticoagulant control achieved in an anticoagulation management service after transfer of management to the primary care physician. Pharmacotherapy, 2012; 32:112–119.
18.
HassanS, NaboushA, RadbelJ, AsaadR, AlkaiedH, DemissieS, et al.Telephone-based anticoagulation management in the homebound setting: A retrospective observational study. Int J Gen Med, 2013; 6:869–875.
19.
WittDM, HumphriesTL. A retrospective evaluation of the management of excessive anticoagulation in an established clinical pharmacy anticoagulation service compared to traditional care. J Thromb Thrombolysis, 2003; 15:113–118.
20.
WassonJ, GaudetteC, WhaleyF, SauvigneA, BaribeauP, WelchHG. Telephone care as a substitute for routine clinic follow-up. JAMA, 1992; 267:1788–1793.
21.
InglisSC, ClarkRA, McAlisterFA, StewartS, ClelandJG. Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review. Eur J Heart Fail, 2011; 13:1028–1040.
22.
TravisJ, RoederK, WaltersH, PietteJ, HeislerM, GanoczyD, et al.Telephone-based mutual peer support for depression: A pilot study. Chronic Ill, 2010; 6:183–191.
23.
McKayJR, LynchKG, ShepardDS, PettinatiHM. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes. Arch Gen Psychiatry, 2005; 62:199–207.
24.
QuanJ, LeeAK, HandleyMA, RatanawongsaN, SarkarU, TsengS, et al.Automated telephone self-management support for diabetes in a low-income health plan: A health care utilization and cost analysis. Popul Health Manag, 2015; 18:412–420.
25.
RobinsonJG, ConroyC, WickemeyerWJ. A novel telephone-based system for management of secondary prevention to a low-density lipoprotein cholesterol ≤100 mg/dL. Am J Cardiol, 2000; 85:305–308.
26.
LeeM, WangM, LiuJ, HolbrookA. Do telehealth interventions improve oral anticoagulation management? A systematic review and meta-analysis. J Thromb Thrombolysis, 2018; 45:325–336.
27.
WatermanAD, BanetG, MilliganPE, FrazierA, VerzinoE, WaltonB, et al.Patient and physician satisfaction with a telephone-based anticoagulation service. J Gen Intern Med, 2001;:460–463.
28.
GoldbergY, MeytesD, ShabtaiE, ShinronO, ShainbergB, SeligsohnU, et al.Monitoring oral anticoagulant therapy by telephone communication. Blood Coagul Fibrinolysis, 2005; 16:227–230.
29.
MohermanLJ, KolarMM. Complication rates for a telephone-based anticoagulation service. Am J Health Syst Pharm, 1999; 56:1540–1542.
30.
StoudenmireLG, DeRmerCE, ElewaH. Telephone versus office-based management of warfarin: Impact on international normalized ratios and outcomes. Int J Hematol, 2014; 100:119–124.
31.
Cochrane Effective Practice and Organisation of Care: Trusted evidence. Informed decisions. Better health Oxford: Cochrane Effective Practice and Organisation of Care (EPOC). 2017. Available at: http://epoc.cochrane.org/epoc-specific-resources-review-authors (last accessed April28, 2017).
32.
MoherD, LiberatiA, TetzlaffJ, AltmanDG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med, 2009; 151:264–269.
33.
Cochrane Effective Practice and Organisation of Care (EPOC). Summary assessments of the risk of bias. EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services. 2013. Available at: http://epoc.cochrane.org/epoc-specific-resources-review-authors (last accessed April28, 2017).
34.
Cochrane Effective Practice and Organisation of Care (EPOC). Suggested risk of bias criteria for EPOC reviews. EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services. 2016. Available at: http://epoc.cochrane.org/epoc-specific-resources-review-authors (last accessed April28, 2017).
HigginsJPT, GreenS, eds. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration. 2011. Available at: www.cochrane-handbook.org (last accessed January6, 2017).
37.
ZhongB. How to calculate sample size in randomized controlled trial?. J Thorac Dis, 2009; 1:51–54.
38.
SchulmanS, ParpiaS, StewartC, Rudd-ScottL, JulianJA, LevineM. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: A randomized trial. Ann Intern Med, 2011; 155:653–659, w201–w653.
39.
BlissitKT, MullenixML, BrittainKG. Evaluation of time in therapeutic range on warfarin therapy between face-to-face and telephone follow-up in a VA Medical Center. J Pharm Technol, 2015; 31:78–83.
40.
CryderBT, FelczakMA, DarkwaA, PatelH, JanociakJD, RihaniR. Transition of stable patients from traditional anticoagulation clinic services to telephonic management. Int J Clin Pharm, 2017; 39:569–572.
41.
HallD, BuchananJ, HelmsB, EbertsM, MarkS, ManolisC, et al.Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care. Pharmacotherapy, 2011; 31:686–694.
42.
LeeJC, HornerKE, KrummelML, McDanelDL. Clinical and financial outcomes evaluation of multimodal pharmacist warfarin management of a statewide urban and rural population. J Pharm Pract, 2018; 31:150–156.
43.
StaresinicAG, SorknessCA, GoodmanBM, PigarelliDW. Comparison of outcomes using 2 delivery models of anticoagulation care. Arch Int Med, 2006; 166:997–1002.
44.
WittDM, SadlerMA, ShanahanRL, MazzoliG, TillmanDJ. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest, 2005; 127:1515–1522.
45.
WittkowskyAK, NutescuEA, BlackburnJ, MullinsJ, VatsV, et al.Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting. Chest, 2006; 130:1385–1389.
46.
PuttarakP, SawangjitR, ChaiyakunaprukN. Efficacy and safety of Derris scandens (Roxb.) Benth. for musculoskeletal pain treatment: A systematic review and meta-analysis of randomized controlled trials. J Ethnopharmacol, 2016; 194:316–323.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
